Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The SWI/SNF chromatin remodeling complex plays a crucial role in cancer development and is frequently altered in various cancers.
• Somatic mutations and aberrant DNA methylation are known mechanisms of SWI/SNF complex inactivation.
• Limited analysis exists regarding SWI/SNF alterations in esophageal squamous cell carcinoma (ESCC).

Purpose of the Study:

• To investigate the frequency and types of SWI/SNF complex somatic mutations in ESCC.
• To identify components of the SWI/SNF complex that undergo aberrant DNA methylation in ESCC.
• To determine the stage at which SWI/SNF complex mutations occur during ESCC development.

Main Methods:

• Deep sequencing of SWI/SNF complex components in 92 ESCC samples.
• Analysis of mutant allele frequency to assess mutation prevalence in cancer cells.
• BeadChip array analysis to detect aberrant promoter methylation of SWI/SNF components in 52 ESCC samples.

Main Results:

• Somatic mutations in 7 SWI/SNF genes (ARID1A, ARID2, ATRX, PBRM1, SMARCA4, SMARCAL1, SMARCC1) were identified in 8.7% of ESCCs.
• Mutations were observed in key functional domains of SMARCA4 and PBRM1.
• Aberrant promoter methylation of ACTL6B was found in 34.6% of ESCCs.
• Mutant allele frequencies indicated SWI/SNF mutations are present in a significant fraction of cancer cells.

Conclusions:

• Both genetic mutations and epigenetic alterations of the SWI/SNF complex are prevalent in ESCC.
• These findings suggest that SWI/SNF alterations are early events in esophageal squamous cell carcinogenesis.
• The study highlights the importance of the SWI/SNF complex in ESCC development.